Stoke Therapeutics, Inc.

Historical 13F Holders

Symbol
STOK
CUSIP
86150R107
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 158 67.7 M $1.57 B
2025 Q2 138 68.9 M $782 M
2025 Q1 130 63.4 M $422 M
2024 Q4 135 58.3 M $643 M
2024 Q3 126 58.6 M $720 M
2024 Q2 123 66.1 M $892 M
2024 Q1 117 62.5 M $843 M
2023 Q4 89 50.0 M $263 M
2023 Q3 104 44.0 M $173 M
2023 Q2 107 46.5 M $495 M
2023 Q1 100 44.6 M $372 M
2022 Q4 111 40.7 M $376 M
2022 Q3 108 42.3 M $544 M
2022 Q2 96 43.1 M $569 M
2022 Q1 103 41.4 M $871 M
2021 Q4 98 35.5 M $856 M
2021 Q3 92 19.4 M $492 M
2021 Q2 102 20.9 M $703 M
2021 Q1 114 39.1 M $1.52 B
2020 Q4 103 38.7 M $2.40 B
2020 Q3 93 34.6 M $1.16 B
2020 Q2 72 34.9 M $825 M
2020 Q1 69 34.8 M $796 M
2019 Q4 66 33.6 M $952 M
2019 Q3 56 16.1 M $341 M
2019 Q2 49 14.3 M $410 M